10Springtide announced that it has completed a $18.1 million Series A round of equity financing led by Deerfield Management Company and Optum Ventures. Springtide is a multi-site practice treating children with autism spectrum disorder (ASD) and developmental delays and disabilities. Springtide will use funds from its Series A round to enhance its clinical operations and ensure quality of care as it expands into new markets. It will also focus on commercializing its technology platform for remote care extensions, data capture for automated reporting and outcomes measurement, and parent engagement.
Springtide provides a range of services tailored to each child’s needs, including applied behavioral analysis, speech therapy, occupational therapy, and physical therapy. Its technology platform offers remote video treatments, parent coaching, family scheduling and engagement tools, as well as enhanced support, supervision and quality reviews, for therapists collaborating together on a child’s care. Springtide was launched by Redesign Health.
Representatives from Deerfield and Optum Ventures will join Springtide’s board of directors. Deerfield invests across health care and has an extensive health care services and technology portfolio. Along with participating in the Series A round, Optum Ventures will provide strategic guidance and support from its network of health care and analytic assets.
Springtide is an interdisciplinary multi-site practice treating children with autism spectrum disorder (ASD) and developmental delays. Its mission is to bring accessible, high quality, and affordable care to families through their centers, technology and family-centric practice.
This was reported by Springtide on November 12, 2020.
Contact information: Erik Milster, 120/80 MKTG for Springtide, 126 Monroe Turnpike, Trumbull, Connecticut 06611; 203-880-5495; Email: erik@120over80mktg.com; Website: https://www.myspringtide.com
